◀ Back to EPO

EDN2 — EPO

Text-mined interactions from Literome

Jelkmann et al., Ann Hematol 2004 (Neoplasms) : Epo promotes angiogenesis and stimulates the production of endothelin and other vasoactive mediators
Kita et al., J Immunol 1995 : MBP ( 10 micrograms/ml ) and EPO ( 0.1 micrograms/ml ) induced EDN release comparable with one of the strongest agonists for eosinophils, secretory IgA ... Pretreatment of cells with dibutyryl cAMP or cytochalasin B completely abolished the EDN release induced by MBP and EPO , suggesting that the effects of MBP and EPO are not due to cytotoxic lysis of the cells
Hon et al., Artif Organs 1995 (Kidney Failure, Chronic) : Lack of a fast acting effect of erythropoietin on arterial blood pressure and endothelin level ... This study was designed to explore the presence, if any, of fast acting effects of EPO on the arterial blood pressure and endothelin level in vivo
Katoh et al., Life Sci 1994 : Direct evidence for erythropoietin induced release of endothelin from peripheral vascular tissue
Haller et al., Kidney Int 1996 : Erythropoietin (EPO) induces endothelin expression in endothelial cells ( EC ) and has angiogenic effects